Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 712 of 6351
-
Could a pill replace the COVID-19 booster shot?
Vaccine OngoingThe primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine tablet VXA-CoV2-3.3 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus D…
Phase 2 • Sponsor: Vaxart • Aim: Vaccine
Last updated Jun 27, 2026 14:02 UTC
-
New RSV vaccine shows promise for seniors in korea
Vaccine CompletedThe goal of this clinical trial is to quantify the immune response in older Korean adults after a RSVpreF vaccination. It will also learn about the safety and tolerability of RSVpreF vaccination. The main questions it aims to answer are: What local reactions and systemic events …
Phase 3 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 09:03 UTC
-
Can telehealth stop HIV in its tracks? new study tests two approaches
Prevention Recruiting nowThe purpose of this study is to test 2 different ways to offer medications to prevent human immunodeficiency virus (HIV), cure hepatitis C virus (HCV) (if applicable) and treat substance use disorder (if desired) in people who inject drugs.
Sponsor: University of Miami • Aim: Prevention
Last updated Jun 27, 2026 09:06 UTC
-
Can a new drug slow Alzheimer's? major study launches
Disease control Recruiting nowThe main purpose of this study is to evaluate the long-term effectiveness of donanemab plus usual care versus usual care alone in participants with early symptomatic AD. The study will employ a prospective, observational cohort design with participant management resembling real-w…
Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New personalized cancer vaccine shows promise in early trial
Disease control OngoingPhase I/II multicenter, open-label, single-arm trial in patients to evaluate the safety and effect of NECVAX-NEO1 administered in combination with PD-1/PD-L1 mABs in patients with solid tumors. Patients with solid tumors who will be treated with approved standard of care (SoC) PD…
Phase 1/2 • Sponsor: NEC Bio B.V • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
A surgical twist that could save ejaculation during prostate surgery
Disease control CompletedSurgery to relieve urinary blockage caused by an enlarged prostate works well, but most men lose antegrade ejaculation afterwards, because semen passes backwards into the bladder instead of forwards. For sexually active men this is an important concern and a common reason for del…
Sponsor: ALI KAMAL M. SAMI • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New antitoxin aims to speed kidney recovery in kids with e. coli infection
Disease control Recruiting nowThe objectives of this study are to evaluate the efficacy, safety, and pharmacokinetics of INM004 in pediatric patients with Hemolytic Uremic Syndrome associated to infection by Shiga toxin-producing Escherichia coli (STEC-HUS).
Phase 3 • Sponsor: Inmunova S.A. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a guided Self-Care plan tame atrial Fibrillation's return?
Symptom relief CompletedAim The investigators will validate the feasibility and effectiveness of a self-management intervention program based on the Common-Sense Model of Self-Regulation for patients after atrial fibrillation ablation. This study aims to analyze the effects of the intervention program o…
Sponsor: Binzhou People's Hospital • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Friendly bacteria vs. vaginal infections: a new trial puts probiotics to the test
Disease control CompletedThis virtual randomized controlled trial evaluates the efficacy of a prebiotic and probiotic supplement in providing relief from symptoms associated with bacterial vaginosis and yeast infections. Participants will be randomized into three groups-test product, active placebo, and …
Sponsor: Happy V • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat lymphoma
Disease control Recruiting nowThis is an open-label phase I study to determine the safety and recommended phase 2 dose (RP2D) of Senza5 CART5 cells in patients with relapsed or refractory CD5 positive nodal T cell NHL. RP2D will be based on the safety, tolerability, pharmacokinetics, and preliminary efficacy …
Phase 1 • Sponsor: Vittoria Biotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Can a single tool outperform the standard for colon polyp removal?
Disease control Recruiting nowThe goal of this clinical trial is to learn whether a new endoscopic device called the Speedboat works as well or better than the standard needle knife for removing large colonic nonpedunculated polyps. The study will also evaluate the safety of the Speedboat device. The main ai…
Sponsor: Mahidol University • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Could a migraine injection also heal caregiver burnout?
Symptom relief CompletedTo evaluate the reduction of emotional burden (measured by Relative Stress Scale-RSS) of caregivers of migraine patients with Depressive Symptoms after 6 months after the first injection of fremanezumab.
Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico • Aim: Symptom relief
Last updated Sep 04, 2026 00:00 UTC
-
New drug aims to reduce deaths from severe lung failure
Disease control Recruiting nowBTI-203 is a randomized, double-blind, placebo-controlled, multicenter, Phase 2 proof-of-concept (POC) study to evaluate the efficacy and safety of rhu-pGSN plus standard of care (SOC) in subjects with moderate-to-severe ARDS (P/F ratio ≤150) due to pneumonia or other infections.…
Phase 2 • Sponsor: BioAegis Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Sound waves to zap hypertension? new trial tests ultrasound treatment
Disease control Recruiting nowThe primary objective of the THRIVE Pivotal study is to demonstrate the adjunctive effectiveness and the safety of the TIVUS system in: 1. subjects with uncontrolled hypertension (HTN) receiving 0 - 2 anti-hypertensive drugs of different classes in whom the anti-hypertensive med…
Sponsor: SoniVie Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Experimental CAR-T therapy targets Hard-to-Treat myeloma
Disease control Recruiting nowThe purpose of this clinical trial is to learn if allogeneic cord blood-derived CAR-T cell drug works to treat Multiple Myeloma (MM) including Bone-related extramedullary (EMB) disease and extramedullary extraosseous disease(EME) in adults. It will also learn about the safety of …
Phase 1 • Sponsor: Xi'an No.3 Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Wrist-Worn nerve stimulator aims to tame atrial fibrillation after ablation
Disease control OngoingDetermine the role of vagal/median nerve stimulation using the CardiaCare RR2 home care wearable neuromodulation system on suppressing atrial arrhythmias and related symptoms in patients who have undergone AF ablation. The study population will be comprised of adults (age ≥18 yrs…
Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Custom DNA vaccine targets Kids' brain tumors in early trial
Vaccine Recruiting nowThe purpose of this research study is to learn about the safety and feasibility of giving a personalized DNA vaccine to people with central nervous system tumors that have returned or have been resistant to treatment.
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Vaccine
Last updated Jun 27, 2026 12:30 UTC
-
New drug targets tough cancers in early trial
Disease control Recruiting nowThe goal of this YH42946-101 is to evaluate the safety, Tolerability, Pharmacokinetics and anti-tumor activity of YH42946 in patients with locally advanced of metastatic solid tumors with HER2 aberration and EGFR exon 20 insertions.
Phase 1/2 • Sponsor: Yuhan Corporation • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
New pill hopes to slow rare brain disease MSA
Disease control Recruiting nowThe primary objective of the study is to evaluate the efficacy of TEV-56286 administered orally for the treatment of adult participants with Multiple System Atrophy (MSA). A secondary objective of the study is to evaluate specific efficacy parameters of TEV-56286. Another secon…
Phase 2 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Heart study aims to find best treatment for minorities with clogged arteries
Disease control Recruiting nowThis is a research study in minorities to compare the outcomes of two procedures that restore blood flow to the arteries of the heart. In one procedure the blockages are ballooned and then stented with a small wire mesh tube through a small incision in the wrist or the groin. The…
Phase 3 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC